Dairy fats and cardiovascular disease: Do we really need to be concerned?

Foods

Volumn 7, Issue 3, 2018, Pages

  Lordan, Ronan ^a   Tsoupras, Alexandros ^a   Mitra, Bhaskar ^b   Zabetakis, Ioannis ^a  

^a UNIVERSITY OF LIMERICK   (Ireland)

^b Extrx Oy   (Finland)

Author keywords

Atherosclerosis; Cardiometabolic risk factors; Cardiovascular diseases; Cheese; Inflammation; Kefir; Milk; Saturated fatty acids; Yoghurt

Indexed keywords

EID: 85046630338     PISSN: None     EISSN: 23048158     Source Type: Journal    
DOI: 10.3390/foods7030029     Document Type: Review

References (269)

1. Wilkins, E.; Wilson, L.; Wickramasinghe, K.; Bhatnagar, P.; Leal, J.; Luengo-Fernandez, R.; Burns, R.; Rayner, M.; Townsend, N. European Cardiovascular Disease Statistics 2017; European Heart Network: Brussels, Belgium, 2017.
2. Benjamin, E.J.; Blaha, M.J.; Chiuve, S.E.; Cushman, M.; Das, S.R.; Deo, R.; de Ferranti, S.D.; Floyd, J.; Fornage, M.; Gillespie, C.; et al. Heart disease and stroke statistics-2017 update: A report from the american heart association. Circulation 2017, 135, e146-e603. [CrossRef] [PubMed]
3. Health Service Executive Ireland. Coronary Heart Disease. Available online: http://www.hse.ie/eng/health/az/C/Coronary-heart-disease/ (accessed on 20 January 2017).
4. Lordan, R.; Zabetakis, I. Invited review: The anti-inflammatory properties of dairy lipids. J. Dairy Sci. 2017, 100, 4197-4212. [CrossRef] [PubMed]
5. O'Keefe, J.H.; Gheewala, N.M.; O'Keefe, J.O. Dietary strategies for improving post-prandial glucose, lipids, inflammation, and cardiovascular health. J. Am. Coll. Cardiol. 2008, 51, 249-255. [CrossRef] [PubMed]
6. Mozaffarian, D.; Appel, L.J.; Van Horn, L. Components of a cardioprotective diet new insights. Circulation 2011, 123, 2870-2891. [CrossRef] [PubMed]
7. Kapaj, A.; Deci, E. Chapter 7-World milk production and socio-economic factors effecting its consumption a2-Watson, ronald ross. In Dairy in Human Health and Disease Across the Lifespan; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 107-115.
8. Artaud-Wild, S.M.; Connor, S.; Sexton, G.; Connor, W.E. Differences in coronary mortality can be explained by differences in cholesterol and saturated fat intakes in 40 countries but not in France and Finland. A paradox. Circulation 1993, 88, 2771-2779. [CrossRef] [PubMed]
9. Turpeinen, O. Effect of cholesterol-lowering diet on mortality from coronary heart disease and other causes. Circulation 1979, 59, 1-7. [CrossRef] [PubMed]
10. Huth, P.J.; Park, K.M. Influence of dairy product and milk fat consumption on cardiovascular disease risk: A review of the evidence. Adv. Nutr. 2012, 3, 266-285. [CrossRef] [PubMed]
11. Grosso, G. Chapter 30-Milk and chronic-degenerative diseases: Main components and potential mechanisms a2-Watson, ronald ross. In Dairy in Human Health and Disease Across the Lifespan; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 385-393.
12. Guo, J.; Astrup, A.; Lovegrove, J.A.; Gijsbers, L.; Givens, D.I.; Soedamah-Muthu, S.S. Milk and dairy consumption and risk of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies. Eur. J. Epidemiol. 2017, 32, 269-287. [CrossRef] [PubMed]
13. Goldbohm, R.A.; Chorus, A.M.J.; Garre, F.G.; Schouten, L.J.; van den Brandt, P.A. Dairy consumption and 10-y total and cardiovascular mortality: A prospective cohort study in The Netherlands. Am. J. Clin. Nutr. 2011, 93, 615-627. [CrossRef] [PubMed]
14. Lamarche, B.; Givens, D.I.; Soedamah-Muthu, S.; Krauss, R.M.; Jakobsen, M.U.; Bischoff-Ferrari, H.A.; Pan, A.; Després, J.-P. Does milk consumption contribute to cardiometabolic health and overall diet quality? Can. J. Cardiol. 2016, 32, 1026-1032. [CrossRef] [PubMed]
15. Dumas, A.-A.; Lapointe, A.; Dugrenier, M.; Provencher, V.; Lamarche, B.; Desroches, S. A systematic review of the effect of yogurt consumption on chronic diseases risk markers in adults. Eur. J. Clin. Nutr. 2017, 56, 1375-1392. [CrossRef] [PubMed]
16. Alexander, D.D.; Bylsma, L.C.; Vargas, A.J.; Cohen, S.S.; Doucette, A.; Mohamed, M.; Irvin, S.R.; Miller, P.E.; Watson, H.; Fryzek, J.P. Dairy consumption and CVD: A systematic review and meta-analysis. Br. J. Nutr. 2016, 115, 737-750. [CrossRef] [PubMed]
17. Qin, L.-Q.; Xu, J.-Y.; Han, S.-F.; Zhang, Z.-L.; Zhao, Y.-Y.; Szeto, I.M. Dairy consumption and risk of cardiovascular disease: An updated meta-analysis of prospective cohort studies. Asia Pac. J. Clin. Nutr. 2015, 24, 90-100. [PubMed]
18. Crichton, G.E.; Elias, M.F. Dairy food intake and cardiovascular health: The maine-syracuse study. Adv. Dairy Res. 2014, 2, 1-8. [CrossRef]
19. Crichton, G.E.; Alkerwi, A. Dairy food intake is positively associated with cardiovascular health: Findings from observation of cardiovascular risk factors in Luxembourg study. Nutr. Res. 2014, 34, 1036-1044. [CrossRef] [PubMed]
20. Gijsbers, L.; Ding, E.L.; Malik, V.S.; de Goede, J.; Geleijnse, J.M.; Soedamah-Muthu, S.S. Consumption of dairy foods and diabetes incidence: A dose-response meta-analysis of observational studies. Am. J. Clin. Nutr. 2016, 103, 1111-1124. [CrossRef] [PubMed]
21. Lu, L.; Xun, P.; Wan, Y.; He, K.; Cai, W. Long-term association between dairy consumption and risk of childhood obesity: A systematic review and meta-analysis of prospective cohort studies. Eur. J. Clin. Nutr. 2016, 70, 414-423. [CrossRef] [PubMed]
22. Crichton, G.E.; Alkerwi, A. Whole-fat dairy food intake is inversely associated with obesity prevalence: Findings from the observation of cardiovascular risk factors in Luxembourg study. Nutr. Res. 2014, 34, 936-943. [CrossRef] [PubMed]
23. Lee, K.; Cho, W. The consumption of dairy products is associated with reduced risks of obesity and metabolic syndrome in Korean women but not in men. Nutrients 2017, 9, 630. [CrossRef] [PubMed]
24. Chen, G.C.; Szeto, I.; Chen, L.; Han, S.; Li, Y.; van Hekezen, R.; Qin, L. Dairy products consumption and metabolic syndrome in adults: Systematic review and meta-analysis of observational studies. Sci. Rep. 2015, 5, 14606. [CrossRef] [PubMed]
25. Liu, A.G.; Ford, N.A.; Hu, F.B.; Zelman, K.M.; Mozaffarian, D.; Kris-Etherton, P.M. A healthy approach to dietary fats: Understanding the science and taking action to reduce consumer confusion. Nutr. J. 2017, 16, 53. [CrossRef] [PubMed]
26. Rousseau, S. The celebrity quick-fix. Food Cult. Soc. 2015, 18, 265-287. [CrossRef]
27. United States Department of Health and Human Services. Dietary Guidelines for Americans 2015-2020; Skyhorse Publishing Inc.: New York, NY, USA, 2017.
28. Health Service Executive Ireland. Healthy Food for Life Guidelines. Available online: http://www.hse.ie/eng/about/Who/healthwellbeing/Our-Priority-Programmes/HEAL/Healthy-Eating-Guidelines/ (accessed on 17 January 2018).
29. Weaver, C.M. How sound is the science behind the dietary recommendations for dairy? Am. J. Clin. Nutr. 2014, 99, 1217S-1222S. [CrossRef] [PubMed]
30. Bantle, J.P.; Wylie-Rosett, J.; Albright, A.L.; Apovian, C.M.; Clark, N.G.; Franz, M.J.; Hoogwerf, B.J.; Lichtenstein, A.H.; Mayer-Davis, E.; Mooradian, A.D. Nutrition recommendations and interventions for diabetes: A position statement of the American Diabetes Association. Diabetes Care 2008, 31, S61-S78. [PubMed]
31. Benatar, J.R. Chapter 20-Does dairy food have effects on cardiovascular disease and cardiometabolic risk? A2-Watson, ronald ross. In Dairy in Human Health and Disease Across the Lifespan; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 263-271.
32. Harvard School of Public Health. Healthy Eating Plate and Healthy Eating Pyramid. Available online: https://www.hsph.harvard.edu/nutritionsource/healthy-eating-plate/ (accessed on 21 January 2018).
33. National Health and Medical Research Council. Australian Dietary Guidelines Ageing; Department of Health and Ageing, Ed.; National Health and Medical Research Council Canberra: Canberra, Australia, 2013.
34. Markey, O.; Vasilopoulou, D.; Givens, D.I.; Lovegrove, J.A. Dairy and cardiovascular health: Friend or foe? Nutr. Bull. 2014, 39, 161-171. [CrossRef] [PubMed]
35. Wade, A.T.; Davis, C.R.; Dyer, K.A.; Hodgson, J.M.; Woodman, R.J.; Keage, H.A.; Murphy, K.J. A mediterranean diet to improve cardiovascular and cognitive health: Protocol for a randomised controlled intervention study. Nutrients 2017, 9, 145. [CrossRef] [PubMed]
36. Van Ballegooijen, A.J.; Beulens, J.W. The role of vitamin K status in cardiovascular health: Evidence from observational and clinical studies. Curr. Nutr. Rep. 2017, 6, 197-205. [CrossRef] [PubMed]
37. Heaney, R.P. Calcium, dairy products and osteoporosis. J. Am. Coll. Nutr. 2000, 19, 83S-99S. [CrossRef] [PubMed]
38. Edem, D.O. Palm oil: Biochemical, physiological, nutritional, hematological and toxicological aspects: A review. Plant Foods Hum. Nutr. 2002, 57, 319-341. [CrossRef] [PubMed]
39. Mukherjee, S.; Mitra, A. Health effects of palm oil. J. Hum. Ecol. 2009, 26, 197-203. [CrossRef]
40. Pehowich, D.J.; Gomes, A.V.; Barnes, J.A. Fatty acid composition and possible health effects of coconut constituents. West Indian Med. J. 2000, 49, 128-133. [PubMed]
41. Visioli, F.; Strata, A. Milk, dairy products, and their functional effects in humans: A narrative review of recent evidence. Adv. Nutr. 2014, 5, 131-143. [CrossRef] [PubMed]
42. Hooper, L.; Summerbell, C.D.; Thompson, R.; Sills, D.; Roberts, F.G.; Moore, H.; Smith, G.D. Reduced or modified dietary fat for preventing cardiovascular disease. Cochrane Database Syst. Rev. 2011. [CrossRef]
43. Micha, R.; Mozaffarian, D. Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: A fresh look at the evidence. Lipids 2010, 45, 893-905. [CrossRef] [PubMed]
44. Jakobsen, M.U.; O'Reilly, E.J.; Heitmann, B.L.; Pereira, M.A.; Bälter, K.; Fraser, G.E.; Goldbourt, U.; Hallmans, G.; Knekt, P.; Liu, S. Major types of dietary fat and risk of coronary heart disease: A pooled analysis of 11 cohort studies. Am. J. Clin. Nutr. 2009, 89, 1425-1432. [CrossRef] [PubMed]
45. Nettleton, J.A.; Brouwer, I.A.; Geleijnse, J.M.; Hornstra, G. Saturated fat consumption and risk of coronary heart disease and ischemic stroke: A science update. Ann. Nutr. Metab. 2017, 70, 26-33. [CrossRef] [PubMed]
46. Association, A.H. Dietary Fat and Its Relation to Heart Attacks and Strokes; Report of the Committee for Medical and Community Program of the American Heart Association; American Heart Association: Dallas, TX, USA, 1961; pp. 133-136.
47. Kannel, W.B.; Dawber, T.R.; Kagan, A.; Revotskie, N.; Stokes, J. Factors of risk in the development of coronary heart disease-Six-year follow-up experiencethe Framingham study. Ann. Intern. Med. 1961, 55, 33-50. [CrossRef] [PubMed]
48. La Berge, A.F. How the ideology of low fat conquered America. J. Hist. Med. Allied Sci. 2008, 63, 139-177. [CrossRef] [PubMed]
49. Siri-Tarino, P.W.; Sun, Q.; Hu, F.B.; Krauss, R.M. Meta-analysis of prospective cohort studies evaluating the association of saturated fat with cardiovascular disease. Am. J. Clin. Nutr. 2010, 91, 535-546. [CrossRef] [PubMed]
50. Legrand, P.; Rioux, V. The complex and important cellular and metabolic functions of saturated fatty acids. Lipids 2010, 45, 941-946. [CrossRef] [PubMed]
51. Kubow, S. The influence of positional distribution of fatty acids in native, interesterified and structure-specific lipids on lipoprotein metabolism and atherogenesis. J. Nutr. Biochem. 1996, 7, 530-541. [CrossRef]
52. Astrup, A.; Dyerberg, J.; Elwood, P.; Hermansen, K.; Hu, F.B.; Jakobsen, M.U.; Kok, F.J.; Krauss, R.M.; Lecerf, J.M.; LeGrand, P. The role of reducing intakes of saturated fat in the prevention of cardiovascular disease: Where does the evidence stand in 2010? Am. J. Clin. Nutr. 2011, 93, 684-688. [CrossRef] [PubMed]
53. Lordan, R.; Tsoupras, A.; Zabetakis, I. Phospholipids of animal and marine origin: Structure, function, and anti-inflammatory properties. Molecules 2017, 22, 1964. [CrossRef] [PubMed]
54. Walz, C.P.; Barry, A.R.; Koshman, S.L. Omega-3 polyunsaturated fatty acid supplementation in the prevention of cardiovascular disease. Can. Pharm. J. 2016, 149, 166-173. [CrossRef] [PubMed]
55. Marventano, S.; Kolacz, P.; Castellano, S.; Galvano, F.; Buscemi, S.; Mistretta, A.; Grosso, G. A review of recent evidence in human studies of n-3 and n-6 PUFA intake on cardiovascular disease, cancer, and depressive disorders: Does the ratio really matter? Int. J. Food Sci. Nutr. 2015, 66, 611-622. [CrossRef] [PubMed]
56. Nettleton, J.A.; Legrand, P.; Mensink, R.P. Issfal 2014 debate: It is time to update saturated fat recommendations. Ann. Nutr. Metab. 2015, 66, 104-108. [CrossRef] [PubMed]
57. Livingstone, K.M.; Lovegrove, J.A.; Givens, D.I. The impact of substituting SFA in dairy products with MUFA or PUFA on CVD risk: Evidence from human intervention studies. Nutr. Res. Rev. 2012, 25, 193-206. [CrossRef] [PubMed]
58. Markey, O.; Souroullas, K.; Fagan, C.C.; Kliem, K.E.; Vasilopoulou, D.; Jackson, K.G.; Humphries, D.J.; Grandison, A.S.; Givens, D.I.; Lovegrove, J.A.; et al. Consumer acceptance of dairy products with a saturated fatty acid-reduced, monounsaturated fatty acid-enriched content. J. Dairy Sci. 2017, 100, 7953-7966. [CrossRef] [PubMed]
59. Bayat, A.R.; Tapio, I.; Vilkki, J.; Shingfield, K.J.; Leskinen, H. Plant oil supplements reduce methane emissions and improve milk fatty acid composition in dairy cows fed grass silage-based diets without affecting milk yield. J. Dairy Sci. 2018, 101, 1136-1151. [CrossRef] [PubMed]
60. Fernandez, M.L.; West, K.L. Mechanisms by which dietary fatty acids modulate plasma lipids. J. Nutr. 2005, 135, 2075-2078. [CrossRef] [PubMed]
61. Mensink, R.P.; Zock, P.L.; Kester, A.D.; Katan, M.B. Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: A meta-analysis of 60 controlled trials. Am. J. Clin. Nutr. 2003, 77, 1146-1155. [CrossRef] [PubMed]
62. German, J.B.; Dillard, C.J. Saturated fats: What dietary intake? Am. J. Clin. Nutr. 2004, 80, 550-559. [CrossRef] [PubMed]
63. Lawrence, G.D. Dietary fats and health: Dietary recommendations in the context of scientific evidence. Adv. Nutr. 2013, 4, 294-302. [CrossRef] [PubMed]
64. Skeaff, C.M.; Miller, J. Dietary fat and coronary heart disease: Summary of evidence from prospective cohort and randomised controlled trials. Ann. Nutr. Metab. 2009, 55, 173-201. [CrossRef] [PubMed]
65. Dehghan, M.; Mente, A.; Zhang, X.; Swaminathan, S.; Li, W.; Mohan, V.; Iqbal, R.; Kumar, R.; Wentzel-Viljoen, E.; Rosengren, A.; et al. Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (pure): A prospective cohort study. Lancet 2017, 390, 2050-2062. [CrossRef]
66. Fernandez, M.L.; Calle, M. Revisiting dietary cholesterol recommendations: Does the evidence support a limit of 300 mg/d? Curr. Atheroscler. Rep. 2010, 12, 377-383. [CrossRef] [PubMed]
67. Rong, Y.; Chen, L.; Zhu, T.; Song, Y.; Yu, M.; Shan, Z.; Sands, A.; Hu, F.B.; Liu, L. Egg consumption and risk of coronary heart disease and stroke: Dose-response meta-analysis of prospective cohort studies. BMJ 2013, 346, e8539. [CrossRef] [PubMed]
68. Krauss, R.M.; Eckel, R.H.; Howard, B.; Appel, L.J.; Daniels, S.R.; Deckelbaum, R.J.; Erdman, J.W.; Kris-Etherton, P.; Goldberg, I.J.; Kotchen, T.A.; et al. Aha dietary guidelines. Revision 2000: A Statement for Healthcare professionals From the Nutrition Committee of the American Heart Association. Circulation 2000, 102, 2284-2299. [CrossRef] [PubMed]
69. Genest, J.; McPherson, R.; Frohlich, J.; Anderson, T.; Campbell, N.; Carpentier, A.; Couture, P.; Dufour, R.; Fodor, G.; Francis, G.A.; et al. 2009 canadian cardiovascular society/canadian guidelines for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease in the adult-2009 recommendations. Can. J. Cardiol. 2009, 25, 567-579. [CrossRef]
70. Public Health England. The Eatwell Guide-Government Dietary Recommendations: Government Recommendations for Energy and Nutrients for Males and Females Aged 1-18 Years and 19+ Years; Public Health England: London, UK, 2016.
71. Jang, Y.-A.; Lee, H.-S.; Kim, B.-H.; Lee, Y.-N.; Lee, H.-J.; Moon, J.-J.; Kim, C.-I. Revised dietary guidelines for Koreans. Asia Pac. J. Clin. Nutr. 2008, 17, 55-58. [PubMed]
72. Ministry of Health. Food and Nutrition Guidelines for Healthy Adults: A Background Paper; Ministry of Health: Wellington, New Zealand, 2003.
73. McNamara, D.J. Cholesterol intake and plasma cholesterol: An update. J. Am. Coll. Nutr. 1997, 16, 530-534.
74. Hu, F.B.; Stampfer, M.J.; Rimm, E.B.; Manson, J.E.; Ascherio, A.; Colditz, G.A.; Rosner, B.A.; Spiegelman, D.; Speizer, F.E.; Sacks, F.M.; et al. A prospective study of egg consumption and risk of cardiovascular disease in men and women. JAMA 1999, 281, 1387-1394. [CrossRef] [PubMed]
75. Esrey, K.L.; Joseph, L.; Grover, S.A. Relationship between dietary intake and coronary heart disease mortality: Lipid research clinics prevalence follow-up study. J. Clin. Epidemiol. 1996, 49, 211-216. [CrossRef]
76. Herron, K.L.; Vega-Lopez, S.; Conde, K.; Ramjiganesh, T.; Roy, S.; Shachter, N.S.; Fernandez, M.L. Pre-menopausal women, classified as hypo- or hyper-responders, do not alter their LDL/HDL ratio following a high dietary cholesterol challenge. J. Am. Coll. Nutr. 2002, 21, 250-258. [CrossRef] [PubMed]
77. Fernandez, M.L.; Webb, D. The LDL to HDL cholesterol ratio as a valuable tool to evaluate coronary heart disease risk. J. Am. Coll. Nutr. 2008, 27, 1-5. [CrossRef] [PubMed]
78. Blesso, C. Egg phospholipids and cardiovascular health. Nutrients 2015, 7, 2731. [CrossRef] [PubMed]
79. Mann, G.V.; Spoerry, A. Studies of a surfactant and cholesteremia in the Maasai. Am. J. Clin. Nutr. 1974, 27, 464-469. [CrossRef] [PubMed]
80. Steinmetz, K.A.; Childs, M.T.; Stimson, C.; Kushi, L.H.; McGovern, P.G.; Potter, J.D.; Yamanaka, W.K. Effect of consumption of whole milk and skim milk on blood lipid profiles in healthy men. Am. J. Clin. Nutr. 1994, 59, 612-618. [CrossRef] [PubMed]
81. Sharpe, S.J.; Gamble, G.D.; Sharpe, D.N. Cholesterol-lowering and blood pressure effects of immune milk. Am. J. Clin. Nutr. 1994, 59, 929-934. [CrossRef] [PubMed]
82. Buonopane, G.J.; Kilara, A.; Smith, J.S.; McCarthy, R.D. Effect of skim milk supplementation on blood cholesterol concentration, blood pressure, and triglycerides in a free-living human population. J. Am. Coll. Nutr. 1992, 11, 56-67. [CrossRef] [PubMed]
83. St-Onge, M.-P.; Farnworth, E.R.; Jones, P.J.H. Consumption of fermented and nonfermented dairy products: Effects on cholesterol concentrations and metabolism. Am. J. Clin. Nutr. 2000, 71, 674-681. [CrossRef] [PubMed]
84. Tholstrup, T.; Høy, C.-E.; Andersen, L.N.; Christensen, R.D.K.; Sandström, B. Does fat in milk, butter and cheese affect blood lipids and cholesterol differently? J. Am. Coll. Nutr. 2004, 23, 169-176. [CrossRef] [PubMed]
85. Biong, A.S.; Muller, H.; Seljeflot, I.; Veierod, M.B.; Pedersen, J.I. A comparison of the effects of cheese and butter on serum lipids, haemostatic variables and homocysteine. Br. J. Nutr. 2004, 92, 791-797. [CrossRef] [PubMed]
86. Nestel, P.J.; Chronopulos, A.; Cehun, M. Dairy fat in cheese raises LDL cholesterol less than that in butter in mildly hypercholesterolaemic subjects. Eur. J. Clin. Nutr. 2005, 59, 1059-1063. [CrossRef] [PubMed]
87. Hjerpsted, J.; Leedo, E.; Tholstrup, T. Cheese intake in large amounts lowers LDL-cholesterol concentrations compared with butter intake of equal fat content. Am. J. Clin. Nutr. 2011, 94, 1479-1484. [CrossRef] [PubMed]
88. Brassard, D.; Tessier-Grenier, M.; Allaire, J.; Rajendiran, E.; She, Y.; Ramprasath, V.; Gigleux, I.; Talbot, D.; Levy, E.; Tremblay, A. Comparison of the impact of SFAs from cheese and butter on cardiometabolic risk factors: A randomized controlled trial. Am. J. Clin. Nutr. 2017, 105, 800-809. [CrossRef] [PubMed]
89. Lorenzen, J.K.; Astrup, A. Dairy calcium intake modifies responsiveness of fat metabolism and blood lipids to a high-fat diet. Br. J. Nutr. 2011, 105, 1823-1831. [CrossRef] [PubMed]
90. Givens, D.I. Saturated fats, dairy foods and health: A curious paradox? Nutr. Bull. 2017, 42, 274-282. [CrossRef]
91. Hjerpsted, J.B.; Dragsted, L.O.; Tholstrup, T. Cheese intake lowers plasma cholesterol concentrations without increasing bile acid excretion. J. Nutr. Intermed. Metab. 2016, 3, 12-17. [CrossRef]
92. Walsh, B. The truth about fat. Time Magazine, 12 June 2014; 28-35.
93. Matthan, N.R.; Welty, F.K.; Barrett, P.H.R.; Harausz, C.; Dolnikowski, G.G.; Parks, J.S.; Eckel, R.H.; Schaefer, E.J.; Lichtenstein, A.H. Dietary hydrogenated fat increases high-density lipoprotein apoA-I catabolism and decreases low-density lipoprotein apoB-100 catabolism in hypercholesterolemic women. Arterioscler. Thromb. Vasc. Biol. 2004, 24, 1092-1097. [CrossRef] [PubMed]
94. Zock, P.L.; Katan, M.B. Butter, margarine and serum lipoproteins. Atherosclerosis 1997, 131, 7-16. [CrossRef]
95. Pimpin, L.; Wu, J.H.; Haskelberg, H.; Del Gobbo, L.; Mozaffarian, D. Is butter back? A systematic review and meta-analysis of butter consumption and risk of cardiovascular disease, diabetes, and total mortality. PLoS ONE 2016, 11, e0158118. [CrossRef] [PubMed]
96. United States Senate Select Committee on Nutrition and Human Needs. Dietary Goals for the United States, Supplemental Views; US Goverment Printing Office: Washington, DC, USA, 1977.
97. Reedy, J. How the US Low-Fat Diet Recommendations of 1977 Contributed to the Declining Health of Americans. Ph.D. Thesis, University of Connecticut, Storrs, CT, USA, 2016.
98. Ludwig, D.S. Lowering the bar on the low-fat diet. JAMA 2016, 316, 2087-2088. [CrossRef] [PubMed]
99. Wang, H.; Fox, C.S.; Troy, L.M.; Mckeown, N.M.; Jacques, P.F. Longitudinal association of dairy consumption with the changes in blood pressure and the risk of incident hypertension: The framingham heart study. Br. J. Nutr. 2015, 114, 1887-1899. [CrossRef] [PubMed]
100. Ralston, R.A.; Lee, J.H.; Truby, H.; Palermo, C.E.; Walker, K.Z. A systematic review and meta-analysis of elevated blood pressure and consumption of dairy foods. J. Hum. Hypertens. 2012, 26, 3-13. [CrossRef] [PubMed]
101. Soedamah-Muthu, S.S.; Verberne, L.D.M.; Ding, E.L.; Engberink, M.F.; Geleijnse, J.M. Dairy consumption and incidence of hypertension: A dose-response meta-analysis of prospective cohort studies. Hypertension 2012, 71. [CrossRef] [PubMed]
102. Drouin-Chartier, J.-P.; Brassard, D.; Tessier-Grenier, M.; Côté, J.A.; Labonté, M.-È.; Desroches, S.; Couture, P.; Lamarche, B. Systematic review of the association between dairy product consumption and risk of cardiovascular-related clinical outcomes. Adv. Nutr. 2016, 7, 1026-1040. [CrossRef] [PubMed]
103. Appel, L.J.; Brands, M.W.; Daniels, S.R.; Karanja, N.; Elmer, P.J.; Sacks, F.M. Dietary approaches to prevent and treat hypertension: A Scientific Statement From the American Heart Association. Hypertension 2006, 47, 296-308. [CrossRef] [PubMed]
104. Da Silva, M.S.; Rudkowska, I. Dairy products on metabolic health: Current research and clinical implications. Maturitas 2014, 77, 221-228. [CrossRef] [PubMed]
105. Alonso, A.; Zozaya, C.; Vázquez, Z.; Alfredo Martínez, J.; Martínez-González, M.A. The effect of low-fat versus whole-fat dairy product intake on blood pressure and weight in young normotensive adults. J. Hum. Nutr. Diet. 2009, 22, 336-342. [CrossRef] [PubMed]
106. Spence, L.A.; Cifelli, C.J.; Miller, G.D. The role of dairy products in healthy weight and body composition in children and adolescents. Curr. Nutr. Food Sci. 2011, 7, 40-49. [CrossRef] [PubMed]
107. Vanderhout, S.M.; Birken, C.S.; Parkin, P.C.; Lebovic, G.; Chen, Y.; O'Connor, D.L.; Maguire, J.L.; Collaboration, T.T.K. Relation between milk-fat percentage, vitamin D, and BMI z score in early childhood. Am. J. Clin. Nutr. 2016, 104, 1657-1664. [CrossRef] [PubMed]
108. García Yu, I.A.-L.; Sánchez-Aguadero, N.; Recio-Rodríguez, J.I. Chapter 25-Effect of the fat component of dairy products in cardiovascular health, vascular structure and function a2-Watson, ronald ross. In Nutrients in Dairy and Their Implications on Health and Disease; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 325-332.
109. Drehmer, M.; Pereira, M.A.; Schmidt, M.I.; Alvim, S.; Lotufo, P.A.; Luft, V.C.; Duncan, B.B. Total and full-fat, but not low-fat, dairy product intakes are inversely associated with metabolic syndrome in adults. J. Nutr. 2015, 146, 81-89. [CrossRef] [PubMed]
110. Eussen, S.J.P.M.; van Dongen, M.C.J.M.; Wijckmans, N.; den Biggelaar, L.; Oude Elferink, S.J.W.H.; Singh-Povel, C.M.; Schram, M.T.; Sep, S.J.S.; van der Kallen, C.J.; Koster, A.; et al. Consumption of dairy foods in relation to impaired glucose metabolism and type 2 diabetes mellitus: The Maastricht study. Br. J. Nutr. 2016, 115, 1453-1461. [CrossRef] [PubMed]
111. Soedamah-Muthu, S.S.; Ding, E.L.; Al-Delaimy, W.K.; Hu, F.B.; Engberink, M.F.; Willett, W.C.; Geleijnse, J.M. Milk and dairy consumption and incidence of cardiovascular diseases and all-cause mortality: Dose-response meta-analysis of prospective cohort studies. Am. J. Clin. Nutr. 2011, 93, 158-171. [CrossRef] [PubMed]
112. Tremblay, A.; Gilbert, J.-A. Milk products, insulin resistance syndrome and type 2 diabetes. J. Am. Coll. Nutr. 2009, 28, 91S-102S. [CrossRef] [PubMed]
113. Thorning, T.K.; Bertram, H.C.; Bonjour, J.-P.; De Groot, L.; Dupont, D.; Feeney, E.; Ipsen, R.; Lecerf, J.M.; Mackie, A.; McKinley, M.C. Whole dairy matrix or single nutrients in assessment of health effects: Current evidence and knowledge gaps. Am. J. Clin. Nutr. 2017, 105, 1033-1045. [CrossRef] [PubMed]
114. Guarner, V.; Rubio-Ruiz, M.E. Low-grade systemic inflammation connects aging, metabolic syndrome and cardiovascular disease. In Aging and Health-A Systems Biology Perspective; Karger Publishers: Basel, Switzerland, 2014; Volume 40, pp. 99-106.
115. Vishnu, A.; Gurka, M.J.; DeBoer, M.D. The severity of the metabolic syndrome increases over time within individuals, independent of baseline metabolic syndrome status and medication use: The atherosclerosis risk in communities study. Atherosclerosis 2015, 243, 278-285. [CrossRef] [PubMed]
116. Givens, D.I.; Livingstone, K.M.; Pickering, J.E.; Fekete, Á.A.; Dougkas, A.; Elwood, P.C. Milk: White elixir or white poison? An examination of the associations between dairy consumption and disease in human subjects. Anim. Front. 2014, 4, 8-15. [CrossRef]
117. Laurent, S.; Boutouyrie, P.; Asmar, R.; Gautier, I.; Laloux, B.; Guize, L.; Ducimetiere, P.; Benetos, A. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension 2001, 37, 1236-1241. [CrossRef] [PubMed]
118. Livingstone, K.M.; Lovegrove, J.A.; Cockcroft, J.R.; Elwood, P.C.; Pickering, J.E.; Givens, D.I. Does dairy food intake predict arterial stiffness and blood pressure in men? Evidence from the caerphilly prospective study. Hypertension 2013, 61, 42-47. [CrossRef] [PubMed]
119. Appel, L.J.; Moore, T.J.; Obarzanek, E.; Vollmer, W.M.; Svetkey, L.P.; Sacks, F.M.; Bray, G.A.; Vogt, T.M.; Cutler, J.A.; Windhauser, M.M.; et al. A clinical trial of the effects of dietary patterns on blood pressure. Dash collaborative research group. N. Engl. J. Med. 1997, 336, 1117-1124. [CrossRef] [PubMed]
120. Van Meijl, L.E.; Mensink, R.P. Low-fat dairy consumption reduces systolic blood pressure, but does not improve other metabolic risk parameters in overweight and obese subjects. Nutr. Metab. Cardiovasc. Dis. 2011, 21, 355-361. [CrossRef] [PubMed]
121. Buendia, J.R.; Li, Y.; Hu, F.B.; Cabral, H.J.; Bradlee, M.L.; Quatromoni, P.A.; Singer, M.R.; Curhan, G.C.; Moore, L.L. Regular yogurt intake and risk of cardiovascular disease among hypertensive adults. Am. J. Hypertens. 2018. [CrossRef] [PubMed]
122. Gholami, F.; Khoramdad, M.; Esmailnasab, N.; Moradi, G.; Nouri, B.; Safiri, S.; Alimohamadi, Y. The effect of dairy consumption on the prevention of cardiovascular diseases: A meta-analysis of prospective studies. J. Cardiovasc. Thorac. Res. 2017, 9, 1-11. [CrossRef] [PubMed]
123. Beltrán-Barrientos, L.M.; Hernández-Mendoza, A.; Torres-Llanez, M.J.; González-Córdova, A.F.; Vallejo-Córdoba, B. Invited review: Fermented milk as antihypertensive functional food. J. Dairy Sci. 2016, 99, 4099-4110. [CrossRef] [PubMed]
124. O'Keeffe, M.B.; FitzGerald, R.J. Whey protein hydrolysate induced modulation of endothelial cell gene expression. J. Funct. Foods 2018, 40, 102-109. [CrossRef]
125. Morio, B.; Fardet, A.; Legrand, P.; Lecerf, J.-M. Involvement of dietary saturated fats, from all sources or of dairy origin only, in insulin resistance and type 2 diabetes. Nutr. Rev. 2016, 74, 33-47. [CrossRef] [PubMed]
126. Elwood, P.C.; Pickering, J.E.; Fehily, A.M. Milk and dairy consumption, diabetes and the metabolic syndrome: The caerphilly prospective study. J. Epidemiol. Community Health 2007, 61, 695-698. [CrossRef] [PubMed]
127. Choi, H.K.; Willett, W.C.; Stampfer, M.J.; Rimm, E.; Hu, F.B. Dairy consumption and risk of type 2 diabetes mellitus in men: A prospective study. Arch. Intern. Med. 2005, 165, 997-1003. [CrossRef] [PubMed]
128. Crichton, G.E.; Bryan, J.; Buckley, J.; Murphy, K.J. Dairy consumption and metabolic syndrome: A systematic review of findings and methodological issues. Obes. Rev. 2011, 12, e190-e201. [CrossRef] [PubMed]
129. Fumeron, F.; Lamri, A.; Abi Khalil, C.; Jaziri, R.; Porchay-Baldérelli, I.; Lantieri, O.; Vol, S.; Balkau, B.; Marre, M.; The Data from the Epidemiological Study on the Insulin Resistance Syndrome Study Group. Dairy consumption and the incidence of hyperglycemia and the metabolic syndrome: Results from a french prospective study, data from the epidemiological study on the insulin resistance syndrome (DESIR). Diabetes Care 2011, 34, 813-817. [CrossRef] [PubMed]
130. Benatar, J.R.; Sidhu, K.; Stewart, R.A.H. Effects of high and low fat dairy food on cardio-metabolic risk factors: A meta-analysis of randomized studies. PLoS ONE 2013, 8, e76480. [CrossRef] [PubMed]
131. Tong, X.; Dong, J.Y.; Wu, Z.W.; Li, W.; Qin, L.Q. Dairy consumption and risk of type 2 diabetes mellitus: A meta-analysis of cohort studies. Eur. J. Clin. Nutr. 2011, 65, 1027-1031. [CrossRef] [PubMed]
132. Chen, M.; Sun, Q.; Giovannucci, E.; Mozaffarian, D.; Manson, J.E.; Willett, W.C.; Hu, F.B. Dairy consumption and risk of type 2 diabetes: 3 cohorts of us adults and an updated meta-analysis. BMC Med. 2014, 12, 215. [CrossRef] [PubMed]
133. Gao, D.; Ning, N.; Wang, C.; Wang, Y.; Li, Q.; Meng, Z.; Liu, Y.; Li, Q. Dairy products consumption and risk of type 2 diabetes: Systematic review and dose-response meta-analysis. PLoS ONE 2013, 8, e73965. [CrossRef] [PubMed]
134. Aune, D.; Norat, T.; Romundstad, P.; Vatten, L.J. Dairy products and the risk of type 2 diabetes: A systematic review and dose-response meta-analysis of cohort studies. Am. J. Clin. Nutr. 2013, 98, 1066-1083. [CrossRef] [PubMed]
135. Bergholdt, H.K.M.; Nordestgaard, B.G.; Ellervik, C. Milk intake is not associated with low risk of diabetes or overweight-obesity: A mendelian randomization study in 97,811 Danish individuals. Am. J. Clin. Nutr. 2015, 102, 487-496. [CrossRef] [PubMed]
136. Sluijs, I.; Forouhi, N.G.; Beulens, J.W.J.; van der Schouw, Y.T.; Agnoli, C.; Arriola, L.; Balkau, B.; Barricarte, A.; Boeing, H.; Bueno-de-Mesquita, H.B. The amount and type of dairy product intake and incident type 2 diabetes: Results from the epic-interact study. Am. J. Clin. Nutr. 2012, 96, 382-390. [PubMed]
137. Clifton, P. Chapter 32-The influence of dairy consumption on the risk of type 2 diabetes, metabolic syndrome, and impaired glucose tolerance or insulin resistance: A review of cohort and intervention studies a2-Watson, ronald ross. In Dairy in Human Health and Disease Across the Lifespan; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 411-422.
138. Parodi, P.W. Cooperative action of bioactive components in milk fat with ppars may explain its anti-diabetogenic properties. Med. Hypotheses 2016, 89, 1-7. [CrossRef] [PubMed]
139. Keast, D.; Hill Gallant, K.; Albertson, A.; Gugger, C.; Holschuh, N. Associations between yogurt, dairy, calcium, and vitamin D intake and obesity among U.S. Children aged 8-18 years: NHANES, 2005-2008. Nutrients 2015, 7, 1577. [CrossRef] [PubMed]
140. Walsh, B.; Cullinan, J. Decomposing socioeconomic inequalities in childhood obesity: Evidence from Ireland. Econ. Hum. Biol. 2015, 16, 60-72. [CrossRef] [PubMed]
141. Moore, L.L.; Singer, M.R.; Qureshi, M.M.; Bradlee, M.L. Dairy intake and anthropometric measures of body fat among children and adolescents in NHANES. J. Am. Coll. Nutr. 2008, 27, 702-710. [CrossRef] [PubMed]
142. Bradlee, M.L.; Singer, M.R.; Qureshi, M.M.; Moore, L.L. Food group intake and central obesity among children and adolescents in the third national health and nutrition examination survey (NHANES III). Public Health Nutr. 2009, 13, 797-805. [CrossRef] [PubMed]
143. Wiley, A.S. Dairy and milk consumption and child growth: Is BMI involved? An analysis of NHANES 1999-2004. Am. J. Hum. Biol. 2010, 22, 517-525. [CrossRef] [PubMed]
144. Sayon-Orea, C.; Martínez-González, M.A.; Ruiz-Canela, M.; Bes-Rastrollo, M. Associations between yogurt consumption and weight gain and risk of obesity and metabolic syndrome: A systematic review. Adv. Nutr. 2017, 8, 146S-154S. [CrossRef] [PubMed]
145. Da Silva, M.S.; Rudkowska, I. Dairy nutrients and their effect on inflammatory profile in molecular studies. Mol. Nutr. Food Res. 2015, 59, 1249-1263. [CrossRef] [PubMed]
146. Palur Ramakrishnan, A.V.K.; Varghese, T.P.; Vanapalli, S.; Nair, N.K.; Mingate, M.D. Platelet activating factor: A potential biomarker in acute coronary syndrome? Cardiovasc. Ther. 2017, 35, 64-70. [CrossRef] [PubMed]
147. Castro Faria Neto, H.C.; Stafforini, D.M.; Prescott, S.M.; Zimmerman, G.A. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. Mem. Inst. Oswaldo Cruz 2005, 100, 83-91. [CrossRef] [PubMed]
148. Lordan, R.; Zabetakis, I. Ovine and caprine lipids promoting cardiovascular health in milk and its derivatives. Adv. Dairy Res 2017, 5. [CrossRef]
149. Antonopoulou, S.; Semidalas, C.E.; Koussissis, S.; Demopoulos, C.A. Platelet-activating factor (PAF) antagonists in foods: A study of lipids with PAF or anti-PAF-like activity in cow's milk and yogurt. J. Agric. Food Chem. 1996, 44, 3047-3051. [CrossRef]
150. Poutzalis, S.; Anastasiadou, A.; Nasopoulou, C.; Megalemou, K.; Sioriki, E.; Zabetakis, I. Evaluation of the in vitro anti-atherogenic activities of goat milk and goat dairy products. Dairy Sci. Technol. 2016, 96, 317-327. [CrossRef]
151. Tsorotioti, S.E.; Nasopoulou, C.; Detopoulou, M.; Sioriki, E.; Demopoulos, C.A.; Zabetakis, I. In vitro anti-atherogenic properties of traditional Greek cheese lipid fractions. Dairy Sci. Technol. 2014, 94, 269-281. [CrossRef]
152. Megalemou, K.; Sioriki, E.; Lordan, R.; Dermiki, M.; Nasopoulou, C.; Zabetakis, I. Evaluation of sensory and in vitro anti-thrombotic properties of traditional Greek yogurts derived from different types of milk. Heliyon 2017, 3, e00227. [CrossRef] [PubMed]
153. Da Silva, M.S.; Rudkowska, I. Chapter 22-Macro components in dairy and their effects on inflammation parameters: Preclinical studies a2-Watson, ronald ross. In Nutrients in Dairy and Their Implications on Health and Disease; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 287-302.
154. Stancliffe, R.A.; Thorpe, T.; Zemel, M.B. Dairy attentuates oxidative and inflammatory stress in metabolic syndrome. Am. J. Clin. Nutr. 2011, 94, 422-430. [CrossRef] [PubMed]
155. Thompson, W.G.; Holdman, N.R.; Janzow, D.J.; Slezak, J.M.; Morris, K.L.; Zemel, M.B. Effect of energy-reduced diets high in dairy products and fiber on weight loss in obese adults. Obes. Res. 2005, 13, 1344-1353. [CrossRef] [PubMed]
156. Sofi, F.; Buccioni, A.; Cesari, F.; Gori, A.M.; Minieri, S.; Mannini, L.; Casini, A.; Gensini, G.F.; Abbate, R.; Antongiovanni, M. Effects of a dairy product (pecorino cheese) naturally rich in cis-9, trans-11 conjugated linoleic acid on lipid, inflammatory and haemorheological variables: A dietary intervention study. Nutr. Metab. Cardiovasc. Dis. 2010, 20, 117-124. [CrossRef] [PubMed]
157. Rosado, J.L.; Garcia, O.P.; Ronquillo, D.; Hervert-Hernández, D.; Caamaño, M.D.C.; Martínez, G.; Gutiérrez, J.; García, S. Intake of milk with added micronutrients increases the effectiveness of an energy-restricted diet to reduce body weight: A randomized controlled clinical trial in Mexican women. J. Am. Diet. Assoc. 2011, 111, 1507-1516. [CrossRef] [PubMed]
158. Nestel, P.J.; Pally, S.; MacIntosh, G.L.; Greeve, M.A.; Middleton, S.; Jowett, J.; Meikle, P.J. Circulating inflammatory and atherogenic biomarkers are not increased following single meals of dairy foods. Eur. J. Clin. Nutr. 2012, 66, 25-31. [CrossRef] [PubMed]
159. Esmaillzadeh, A.; Azadbakht, L. Dairy consumption and circulating levels of inflammatory markers among Iranian women. Public Health Nutr. 2010, 13, 1395-1402. [CrossRef] [PubMed]
160. Panagiotakos, D.B.; Pitsavos, C.H.; Zampelas, A.D.; Chrysohoou, C.A.; Stefanadis, C.I. Dairy products consumption is associated with decreased levels of inflammatory markers related to cardiovascular disease in apparently healthy adults: The ATTICA study. J. Am. Coll. Nutr. 2010, 29, 357-364. [CrossRef] [PubMed]
161. Wang, H.; Steffen, L.M.; Vessby, B.; Basu, S.; Steinberger, J.; Moran, A.; Jacobs, D.R.; Hong, C.-P.; Sinaiko, A.R. Obesity modifies the relations between serum markers of dairy fats and inflammation and oxidative stress among adolescents. Obesity 2011, 19, 2404-2410. [CrossRef] [PubMed]
162. Gadotti, T.N.; Norde, M.M.; Rogero, M.M.; Fisberg, M.; Fisberg, R.M.; Oki, E.; Martini, L.A. Dairy consumption and inflammatory profile: A cross-sectional population-based study, São Paulo, Brazil. Nutrition 2017, 48, 1-5. [CrossRef] [PubMed]
163. Van Meijl, L.E.C.; Mensink, R.P. Effects of low-fat dairy consumption on markers of low-grade systemic inflammation and endothelial function in overweight and obese subjects: An intervention study. Br. J. Nutr. 2010, 104, 1523-1527. [CrossRef] [PubMed]
164. Zemel, M.B.; Sun, X.; Sobhani, T.; Wilson, B. Effects of dairy compared with soy on oxidative and inflammatory stress in overweight and obese subjects. Am. J. Clin. Nutr. 2010, 91, 16-22. [CrossRef] [PubMed]
165. Nestel, P.J.; Mellett, N.; Pally, S.; Wong, G.; Barlow, C.K.; Croft, K.; Mori, T.A.; Meikle, P.J. Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults. Br. J. Nutr. 2013, 110, 2242-2249. [CrossRef] [PubMed]
166. Labonté, M.-È.; Cyr, A.; Abdullah, M.M.; Lépine, M.-C.; Vohl, M.-C.; Jones, P.; Couture, P.; Lamarche, B. Dairy product consumption has no impact on biomarkers of inflammation among men and women with low-grade systemic inflammation. J. Nutr. 2014, 144, 1760-1767. [CrossRef] [PubMed]
167. Dugan, C.E.; Aguilar, D.; Park, Y.K.; Lee, J.Y.; Fernandez, M.L. Dairy consumption lowers systemic inflammation and liver enzymes in typically low-dairy consumers with clinical characteristics of metabolic syndrome. J. Am. Coll. Nutr. 2016, 35, 255-261. [CrossRef] [PubMed]
168. Zemel, M.B.; Sun, X. Dietary calcium and dairy products modulate oxidative and inflammatory stress in mice and humans. J. Nutr. 2008, 138, 1047-1052. [CrossRef] [PubMed]
169. De Aguilar-Nascimento, J.E.; Prado Silveira, B.R.; Dock-Nascimento, D.B. Early enteral nutrition with whey protein or casein in elderly patients with acute ischemic stroke: A double-blind randomized trial. Nutrition 2011, 27, 440-444. [CrossRef] [PubMed]
170. Jones, K.W.; Eller, L.K.; Parnell, J.A.; Doyle-Baker, P.K.; Edwards, A.L.; Reimer, R.A. Effect of a dairy-and calcium-rich diet on weight loss and appetite during energy restriction in overweight and obese adults: A randomized trial. Eur. J. Clin. Nutr. 2013, 67, 371-376. [CrossRef] [PubMed]
171. Pei, R.; DiMarco, D.M.; Putt, K.K.; Martin, D.A.; Gu, Q.; Chitchumroonchokchai, C.; White, H.M.; Scarlett, C.O.; Bruno, R.S.; Bolling, B.W. Low-fat yogurt consumption reduces biomarkers of chronic inflammation and inhibits markers of endotoxin exposure in healthy premenopausal women: A randomised controlled trial. Br. J. Nutr. 2017, 118, 1043-1051. [CrossRef] [PubMed]
172. Wannamethee, S.G.; Jefferis, B.J.; Lennon, L.; Papacosta, O.; Whincup, P.H.; Hingorani, A.D. Serum conjugated linoleic acid and risk of incident heart failure in older men: The British regional heart study. JAMA 2018, 7, e006653. [CrossRef] [PubMed]
173. De Souza, R.J.; Mente, A.; Maroleanu, A.; Cozma, A.I.; Ha, V.; Kishibe, T.; Uleryk, E.; Budylowski, P.; Schünemann, H.; Beyene, J.; et al. Intake of saturated and trans unsaturated fatty acids and risk of all cause mortality, cardiovascular disease, and type 2 diabetes: Systematic review and meta-analysis of observational studies. BMJ 2015, 351, h3978. [CrossRef] [PubMed]
174. Poudyal, H.; Brown, L. Should the pharmacological actions of dietary fatty acids in cardiometabolic disorders be classified based on biological or chemical function? Prog. Lipid Res. 2015, 59, 172-200. [CrossRef] [PubMed]
175. Micha, R.; Mozaffarian, D. Trans fatty acids: Effects on cardiometabolic health and implications for policy. Prostaglandins Leukot. Essent. Fat. Acids 2008, 79, 147-152. [CrossRef] [PubMed]
176. Ganguly, R.; Pierce, G.N. Trans fat involvement in cardiovascular disease. Mol. Nutr. Food Res. 2012, 56, 1090-1096. [CrossRef] [PubMed]
177. Stone, N.J.; Robinson, J.; Lichtenstein, A.H.; Merz, C.N.B.; Blum, C.B.; Eckel, R.H.; Goldberg, A.C.; Gordon, D.; Levy, D.; Lloyd-Jones, D.M.; et al. 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults; A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines; American College of Cardiology: Washington, DC, USA, 2013.
178. Lichtenstein, A.H.; Appel, L.J.; Brands, M.; Carnethon, M.; Daniels, S.; Franch, H.A.; Franklin, B.; Kris-Etherton, P.; Harris, W.S.; Howard, B. Diet and lifestyle recommendations revision 2006. Circulation 2006, 114, 82-96. [CrossRef] [PubMed]
179. L'Abbé, M.R.; Stender, S.; Skeaff, C.M.; Ghafoorunissa; Tavella, M. Approaches to removing trans fats from the food supply in industrialized and developing countries. Eur. J. Clin. Nutr. 2009, 63, S50-S67. [CrossRef]
180. Dawczynski, C.; Lorkowski, S. Trans-fatty acids and cardiovascular risk: Does origin matter? Expert Rev. Cardiovasc. Ther. 2016, 14, 1001-1005. [CrossRef] [PubMed]
181. Mozaffarian, D.; Katan, M.B.; Ascherio, A.; Stampfer, M.J.; Willett, W.C. Trans fatty acids and cardiovascular disease. N. Engl. J. Med. 2006, 354, 1601-1613. [CrossRef] [PubMed]
182. Wang, Y.; Jacome-Sosa, M.M.; Proctor, S.D. The role of ruminant trans fat as a potential nutraceutical in the prevention of cardiovascular disease. Food Res. Int. 2012, 46, 460-468. [CrossRef]
183. Lichtenstein, A.H. Dietary trans fatty acids and cardiovascular disease risk: Past and present. Curr. Atheroscler. Rep. 2014, 16, 433. [CrossRef] [PubMed]
184. Ascherio, A.; Hennekens, C.H.; Buring, J.E.; Master, C.; Stampfer, M.J.; Willett, W.C. Trans-fatty acids intake and risk of myocardial infarction. Circulation 1994, 89, 94-101. [CrossRef] [PubMed]
185. Gebauer, S.K.; Chardigny, J.-M.; Jakobsen, M.U.; Lamarche, B.; Lock, A.L.; Proctor, S.D.; Baer, D.J. Effects of ruminant trans fatty acids on cardiovascular disease and cancer: A comprehensive review of epidemiological, clinical, and mechanistic studies. Adv. Nutr. 2011, 2, 332-354. [CrossRef] [PubMed]
186. Bassett, C.M.C.; Edel, A.L.; Patenaude, A.F.; McCullough, R.S.; Blackwood, D.P.; Chouinard, P.Y.; Paquin, P.; Lamarche, B.T.; Pierce, G.N. Dietary vaccenic acid has antiatherogenic effects in LDLr−/− mice. J. Nutr. 2010, 140, 18-24. [CrossRef] [PubMed]
187. Van de Vijver, L.; Kardinaal, A.; Couet, C.; Aro, A. Association between trans fatty acid intake and cardiovascular risk factors in Europe: The transfair study. Eur. J. Clin. Nutr. 2000, 54, 126-135. [CrossRef] [PubMed]
188. Martínez-González, M.A.; Salas-Salvadó, J.; Estruch, R.; Corella, D.; Fitó, M.; Ros, E. Benefits of the mediterranean diet: Insights from the predimed study. Prog. Cardiovasc. Dis. 2015, 58, 50-60. [CrossRef] [PubMed]
189. Smit, L.A.; Baylin, A.; Campos, H. Conjugated linoleic acid in adipose tissue and risk of myocardial infarction. Am. J. Clin. Nutr. 2010, 92, 34-40. [CrossRef] [PubMed]
190. Moloney, F.; Toomey, S.; Noone, E.; Nugent, A.; Allan, B.; Loscher, C.E.; Roche, H.M. Antidiabetic effects of cis-9, trans-11-conjugated linoleic acid may be mediated via anti-inflammatory effects in white adipose tissue. Diabetes 2007, 56, 574-582. [CrossRef] [PubMed]
191. Ahn, I.-S.; Choi, B.-H.; Ha, J.-H.; Byun, J.-M.; Shin, H.-G.; Park, K.-Y.; Do, M.-S. Isomer-specific effect of conjugated linoleic acid on inflammatory adipokines associated with fat accumulation in 3T3-L1 adipocytes. J. Med. Food 2006, 9, 307-312. [CrossRef] [PubMed]
192. Mozaffarian, D.; Cao, H.; King, I.B.; Lemaitre, R.N.; Song, X.; Siscovick, D.S.; Hotamisligil, G.K.S. Trans-palmitoleic acid, metabolic risk factors, and new-onset diabetes in us adults. Ann. Intern. Med. 2010, 153, 790-799. [CrossRef] [PubMed]
193. Bolton-Smith, C.; Woodward, M.; Fenton, S.; Brown, C. Does dietary trans fatty acid intake relate to the prevalence of coronary heart disease in Scotland? Eur. Heart J. 1996, 17, 837-845. [CrossRef] [PubMed]
194. Olmedilla-Alonso, B.; Nova-Rebato, E.; García-González, N.; Martín-Diana, A.-B.; Fontecha, J.; Delgado, D.; Gredilla, A.-E.; Bueno, F.; Asensio-Vegas, C. Effect of ewe's (semi-skimmed and whole) and cow's milk yogurt consumption on the lipid profile of control subjects: A crossover study. Food Nutr. Res. 2017, 61, 1391669. [CrossRef] [PubMed]
195. Zoumpopoulou, G.; Pot, B.; Tsakalidou, E.; Papadimitriou, K. Dairy probiotics: Beyond the role of promoting gut and immune health. Int. Dairy J. 2017, 67, 46-60. [CrossRef]
196. Elwood, P.C.; Pickering, J.E.; Givens, D.I.; Gallacher, J.E. The consumption of milk and dairy foods and the incidence of vascular disease and diabetes: An overview of the evidence. Lipids 2010, 45, 925-939. [CrossRef] [PubMed]
197. Darmon, N.; Drewnowski, A. Does social class predict diet quality? Am. J. Clin. Nutr. 2008, 87, 1107-1117. [CrossRef] [PubMed]
198. Hobbs, D.A.; Givens, D.I.; Lovegrove, J.A. Yogurt consumption is associated with higher nutrient intake, diet quality and favourable metabolic profle in children: A cross-sectional analysis using data from years 1-4 of the national diet and nutrition survey, UK. Eur. J. Nutr. 2018, 1-14. [CrossRef]
199. Tognon, G.; Nilsson, L.M.; Shungin, D.; Lissner, L.; Jansson, J.-H.; Renström, F.; Wennberg, M.; Winkvist, A.; Johansson, I. Nonfermented milk and other dairy products: Associations with all-cause mortality. Am. J. Clin. Nutr. 2017, 105, 1502-1511. [CrossRef] [PubMed]
200. Tong, X.; Chen, G.-C.; Zhang, Z.; Wei, Y.-L.; Xu, J.-Y.; Qin, L.-Q. Cheese consumption and risk of all-cause mortality: A meta-analysis of prospective studies. Nutrients 2017, 9, 63. [CrossRef] [PubMed]
201. Kießling, G.; Schneider, J.; Jahreis, G. Long-term consumption of fermented dairy products over 6 months increases HDL cholesterol. Eur. J. Clin. Nutr. 2002, 56, 843-849. [CrossRef] [PubMed]
202. Turner, K.M.; Keogh, J.B.; Clifton, P.M. Dairy consumption and insulin sensitivity: A systematic review of short- and long-term intervention studies. Nutr. Metab. Cardiovasc. Dis. 2015, 25, 3-8. [CrossRef] [PubMed]
203. Hove, K.D.; Brøns, C.; Færch, K.; Lund, S.S.; Rossing, P.; Vaag, A. Effects of 12 weeks of treatment with fermented milk on blood pressure, glucose metabolism and markers of cardiovascular risk in patients with type 2 diabetes: A randomised double-blind placebo-controlled study. Eur. J. Endocrinol. 2015, 172, 11-20. [CrossRef] [PubMed]
204. Houston, D.K.; Driver, K.E.; Bush, A.J.; Kritchevsky, S.B. The association between cheese consumption and cardiovascular risk factors among adults. J. Hum. Nutr. Diet. 2008, 21, 129-140. [CrossRef] [PubMed]
205. Tholstrup, T. Dairy products and cardiovascular disease. Curr. Opin. Lipidol. 2006, 17, 1-10. [CrossRef] [PubMed]
206. Tavani, A.; Gallus, S.; Negri, E.; La Vecchia, C. Milk, dairy products, and coronary heart disease. J. Epidemiol. Community Health 2002, 56, 471-472. [CrossRef] [PubMed]
207. Hjerpsted, J.; Tholstrup, T. Cheese and cardiovascular disease risk: A review of the evidence and discussion of possible mechanisms. Crit. Rev. Food Sci. Nutr. 2016, 56, 1389-1403. [CrossRef] [PubMed]
208. Praagman, J.; Dalmeijer, G.W.; van der Schouw, Y.T.; Soedamah-Muthu, S.S.; Monique Verschuren, W.M.; Bas Bueno-de-Mesquita, H.; Geleijnse, J.M.; Beulens, J.W.J. The relationship between fermented food intake and mortality risk in the European prospective investigation into cancer and nutrition-netherlands cohort. Br. J. Nutr. 2015, 113, 498-506. [CrossRef] [PubMed]
209. Wu, L.; Sun, D. Consumption of yogurt and the incident risk of cardiovascular disease: A meta-analysis of nine cohort studies. Nutrients 2017, 9, 315. [CrossRef] [PubMed]
210. Sayón-Orea, C.; Bes-Rastrollo, M.; Martí, A.; Pimenta, A.M.; Martín-Calvo, N.; Martínez-González, M.A. Association between yogurt consumption and the risk of metabolic syndrome over 6 years in the sun study. BMC Public Health 2015, 15, 170. [CrossRef] [PubMed]
211. Renaud, S.; de Lorgeril, M. Wine, alcohol, platelets, and the french paradox for coronary heart disease. Lancet 1992, 339, 1523-1526. [CrossRef]
212. Lallès, J.-P. Dairy products and the french paradox: Could alkaline phosphatases play a role? Med. Hypotheses 2016, 92, 7-11. [CrossRef] [PubMed]
213. Petyaev, I.M.; Bashmakov, Y.K. Could cheese be the missing piece in the French paradox puzzle? Med. Hypotheses 2012, 79, 746-749. [CrossRef] [PubMed]
214. Parvez, S.; Malik, K.A.; Ah Kang, S.; Kim, H.Y. Probiotics and their fermented food products are beneficial for health. J. Appl. Microbiol. 2006, 100, 1171-1185. [CrossRef] [PubMed]
215. Booth, S.L. Roles for vitamin K beyond coagulation. Annu. Rev. Nutr. 2009, 29, 89-110. [CrossRef] [PubMed]
216. O'Connor, E.M.; Durack, E. Osteocalcin: The extra-skeletal role of a vitamin K-dependent protein in glucose metabolism. J. Nutr. Intermed. Metab. 2017, 7, 8-13. [CrossRef]
217. Walther, B.; Karl, J.P.; Booth, S.L.; Boyaval, P. Menaquinones, bacteria, and the food supply: The relevance of dairy and fermented food products to vitamin K requirements. Adv. Nutr. 2013, 4, 463-473. [CrossRef] [PubMed]
218. Booth, S.L.; Rajabi, A.A. Determinants of vitamin K status in humans. Vitam. Horm. 2008, 78, 1-22. [PubMed]
219. Fu, X.; Harshman, S.G.; Shen, X.; Haytowitz, D.B.; Karl, J.P.; Wolfe, B.E.; Booth, S.L. Multiple vitamin K forms exist in dairy foods. Curr. Dev. Nutr. 2017, 1, e000638. [CrossRef]
220. Shea, M.K.; Holden, R.M. Vitamin K status and vascular calcification: Evidence from observational and clinical studies. Adv. Nutr. 2012, 3, 158-165. [CrossRef] [PubMed]
221. Harshman, S.G.; Shea, M.K. The role of vitamin K in chronic aging diseases: Inflammation, cardiovascular disease, and osteoarthritis. Curr. Nutr. Rep. 2016, 5, 90-98. [CrossRef] [PubMed]
222. Gast, G.C.M.; de Roos, N.M.; Sluijs, I.; Bots, M.L.; Beulens, J.W.J.; Geleijnse, J.M.; Witteman, J.C.; Grobbee, D.E.; Peeters, P.H.M.; van der Schouw, Y.T. A high menaquinone intake reduces the incidence of coronary heart disease. Nutr. Metab. Cardiovasc. Dis. 2009, 19, 504-510. [CrossRef] [PubMed]
223. Nagata, C.; Wada, K.; Tamura, T.; Konishi, K.; Goto, Y.; Koda, S.; Kawachi, T.; Tsuji, M.; Nakamura, K. Dietary soy and natto intake and cardiovascular disease mortality in Japanese adults: The Takayama study. Am. J. Clin. Nutr. 2017, 105, 426-431. [CrossRef] [PubMed]
224. Keyzer, C.A.; Vermeer, C.; Joosten, M.M.; Knapen, M.H.; Drummen, N.E.; Navis, G.; Bakker, S.J.; de Borst, M.H. Vitamin K status and mortality after kidney transplantation: A cohort study. Am. J. Kidney Dis. 2015, 65, 474-483. [CrossRef] [PubMed]
225. Rosa, D.D.; Dias, M.M.S.; Grzeskowiak, Ł.M.; Reis, S.A.; Conceição, L.L.; Peluzio, M.D.C.G. Milk kefir: Nutritional, microbiological and health benefits. Nutr. Res. Rev. 2017, 30, 82-96. [CrossRef] [PubMed]
226. Nestel, P. Chapter 16-Fermented Dairy Foods and Cardiovascular Risk a2-Watson, Ronald Ross. In Dairy in Human Health and Disease Across the Lifespan; Collier, R.J., Preedy, V.R., Eds.; Academic Press: Cambridge, MA, USA, 2017; pp. 225-229.
227. Rosqvist, F.; Smedman, A.; Lindmark-Månsson, H.; Paulsson, M.; Petrus, P.; Straniero, S.; Rudling, M.; Dahlman, I.; Risérus, U. Potential role of milk fat globule membrane in modulating plasma lipoproteins, gene expression, and cholesterol metabolism in humans: A randomized study. Am. J. Clin. Nutr. 2015, 102, 20-30. [CrossRef] [PubMed]
228. Granato, D.; Branco, G.F.; Cruz, A.G.; Faria, J.D.A.F.; Shah, N.P. Probiotic dairy products as functional foods. Compr. Rev. Food Sci. Food Saf. 2010, 9, 455-470. [CrossRef]
229. Shortt, C.; O'Brien, J. Handbook of Functional Dairy Products; CRC Press: Boca Raton, FL, USA, 2016.
230. ® , Colanta) in reducing total and LDL cholesterol in subjects with moderate hypercholesterolemia: A randomized placebo-controlled crossover trial NCT01461798. Lipids Health Dis. 2014, 13, 125. [CrossRef] [PubMed]
231. Law, M. Plant sterol and stanol margarines and health. BMJ 2000, 320, 861-864. [CrossRef] [PubMed]
232. Harland, J.I. Food combinations for cholesterol lowering. Nutr. Res. Rev. 2012, 25, 249-266. [CrossRef] [PubMed]
233. Özer, B.H.; Kirmaci, H.A. Functional milks and dairy beverages. Int. J. Dairy Technol. 2010, 63, 1-15. [CrossRef]
234. Rocha, M.; Banuls, C.; Bellod, L.; Jover, A.; M Victor, V.; Hernandez-Mijares, A. A review on the role of phytosterols: New insights into cardiovascular risk. Curr. Pharm. Des. 2011, 17, 4061-4075. [CrossRef] [PubMed]
235. Yildiz, F. Development and Manufacture of Yogurt and Other Functional Dairy Products; CRC Press Taylor & Francis Group: Boca Raton, FL, USA, 2016; p. 435.
236. Jones, P.J.; Ntanios, F.Y.; Raeini-Sarjaz, M.; Vanstone, C.A. Cholesterol-lowering efficacy of a sitostanol-containing phytosterol mixture with a prudent diet in hyperlipidemic men. Am. J. Clin. Nutr. 1999, 69, 1144-1150. [CrossRef] [PubMed]
237. Hansel, B.; Nicolle, C.; Lalanne, F.; Tondu, F.; Lassel, T.; Donazzolo, Y.; Ferrières, J.; Krempf, M.; Schlienger, J.-L.; Verges, B.; et al. Effect of low-fat, fermented milk enriched with plant sterols on serum lipid profile and oxidative stress in moderate hypercholesterolemia. Am. J. Clin. Nutr. 2007, 86, 790-796. [CrossRef] [PubMed]
238. Mäkinen, O.E.; Wanhalinna, V.; Zannini, E.; Arendt, E.K. Foods for special dietary needs: Non-dairy plant-based milk substitutes and fermented dairy-type products. Crit. Rev. Food Sci. Nutr. 2016, 56, 339-349. [CrossRef] [PubMed]
239. Stall, S.; Adams, G. Can almond milk be called milk? J. Renal Nutr. 2017, 27, e15-e17. [CrossRef]
240. Jeske, S.; Zannini, E.; Arendt, E.K. Evaluation of physicochemical and glycaemic properties of commercial plant-based milk substitutes. Plant Foods Hum. Nutr. 2017, 72, 26-33. [CrossRef] [PubMed]
241. Jenkins, D.J.; Mirrahimi, A.; Srichaikul, K.; Berryman, C.E.; Wang, L.; Carleton, A.; Abdulnour, S.; Sievenpiper, J.L.; Kendall, C.W.; Kris-Etherton, P.M. Soy protein reduces serum cholesterol by both intrinsic and food displacement mechanisms. J. Nutr. 2010, 140, 2302S-2311S. [CrossRef] [PubMed]
242. Liu, X.X.; Li, S.H.; Chen, J.Z.; Sun, K.; Wang, X.J.; Wang, X.G.; Hui, R.T. Effect of soy isoflavones on blood pressure: A meta-analysis of randomized controlled trials. Nutr. Metab. Cardiovasc. Dis. 2012, 22, 463-470. [CrossRef] [PubMed]
243. Messina, M. Soy and health update: Evaluation of the clinical and epidemiologic literature. Nutrients 2016, 8, 754. [CrossRef] [PubMed]
244. Lecomte, M.; Couëdelo, L.; Meugnier, E.; Plaisancié, P.; Létisse, M.; Benoit, B.; Gabert, L.; Penhoat, A.; Durand, A.; Pineau, G.; et al. Dietary emulsifiers from milk and soybean differently impact adiposity and inflammation in association with modulation of colonic goblet cells in high-fat fed mice. Mol. Nutr. Food Res. 2016, 60, 609-620. [CrossRef] [PubMed]
245. O'Connor, A. Got Almond Milk? Dairy Farms Protest Milk Label on Nondairy Drinks. Available online: https://www.nytimes.com/2017/02/13/well/eat/got-almond-milk-dairy-farms-protest-milklabel-on-nondairy-drinks.html?_r=0 (accessed on 17 January 2018).
246. Balthazar, C.; Junior, C.C.; Moraes, J.; Costa, M.; Raices, R.; Franco, R.; Cruz, A.; Silva, A. Physicochemical evaluation of sheep milk yogurts containing different levels of inulin. J. Dairy Sci. 2016, 99, 4160-4168. [CrossRef] [PubMed]
247. Park, Y.W. Impact of goat milk and milk products on human nutrition. Perspect. Agric. Vet. Sci. Nutr. Nat. Resour. 2007, 2. [CrossRef]
248. Costa, M.P.; Monteiro, M.L.G.; Frasao, B.S.; Silva, V.L.M.; Rodrigues, B.L.; Chiappini, C.C.J.; Conte-Junior, C.A. Consumer perception, health information, and instrumental parameters of cupuassu (Theobroma grandiflorum) goat milk yogurts. J. Dairy Sci. 2017, 100, 157-168. [CrossRef] [PubMed]
249. Park, Y.W.; Juárez, M.; Ramos, M.; Haenlein, G.F.W. Physico-chemical characteristics of goat and sheep milk. Small Rumin. Res. 2007, 68, 88-113. [CrossRef]
250. Haenlein, G.F.W. Goat milk in human nutrition. Small Rumin. Res. 2004, 51, 155-163. [CrossRef]
251. Pereira, P.C. Milk nutritional composition and its role in human health. Nutrition 2014, 30, 619-627. [CrossRef] [PubMed]
252. Contarini, G.; Pelizzola, V.; Povolo, M. Content of conjugated linoleic acid in neutral and polar lipid fractions of milk of different ruminant species. Int. Dairy J. 2009, 19, 342-344. [CrossRef]
253. Pintus, S.; Murru, E.; Carta, G.; Cordeddu, L.; Batetta, B.; Accossu, S.; Pistis, D.; Uda, S.; Elena Ghiani, M.; Mele, M.; et al. Sheep cheese naturally enriched in α-linolenic, conjugated linoleic and vaccenic acids improves the lipid profile and reduces anandamide in the plasma of hypercholesterolaemic subjects. Br. J. Nutr. 2013, 109, 1453-1462. [CrossRef] [PubMed]
254. Barłowska, J.; Szwajkowska, M.; Litwinczuk, ´ Z.; Król, J. Nutritional value and technological suitability of milk from various animal species used for dairy production. Compr. Rev. Food Sci. Food Saf. 2011, 10, 291-302. [CrossRef]
255. Haenlein, G.F.W.; Wendorff, W.L. Sheep milk. In Handbook of Milk of Non-Bovine Mammals; Blackwell Publishing Professional: Hoboken, NJ, USA, 2008; pp. 137-194.
256. Balthazar, C.F.; Pimentel, T.C.; Ferrão, L.L.; Almada, C.N.; Santillo, A.; Albenzio, M.; Mollakhalili, N.; Mortazavian, A.M.; Nascimento, J.S.; Silva, M.C.; et al. Sheep milk: Physicochemical characteristics and relevance for functional food development. Compr. Rev. Food Sci. Food Saf. 2017, 16, 247-262. [CrossRef]
257. Molkentin, J. Occurrence and biochemical characteristics of natural bioactive substances in bovine milk lipids. Br. J. Nutr. 2000, 84, 47-53. [CrossRef]
258. Balthazar, C.F.; Cruz, A.G. Sheep milk: An unexplored food matrix to develop functional foods. Inform 2017, 28, 32-33. [CrossRef]
259. Corrêa, A.P.F.; Daroit, D.J.; Coelho, J.; Meira, S.M.M.; Lopes, F.C.; Segalin, J.; Risso, P.H.; Brandelli, A. Antioxidant, antihypertensive and antimicrobial properties of ovine milk caseinate hydrolyzed with a microbial protease. J. Sci. Food Agric. 2011, 91, 2247-2254. [CrossRef] [PubMed]
260. Marsh, A.J.; O'Sullivan, O.; Hill, C.; Ross, R.P.; Cotter, P.D. Sequencing-based analysis of the bacterial and fungal composition of kefir grains and milks from multiple sources. PLoS ONE 2013, 8, e69371. [CrossRef] [PubMed]
261. Farnworth, E.R. Kefir-A complex probiotic. Food Sci. Technol. Bull. 2006, 2, 1-17. [CrossRef]
262. Vieira, C.; Álvares, T.; Gomes, L.; Torres, A.; Paschoalin, V.; Conte-Junior, C. Kefir grains change fatty acid profile of milk during fermentation and storage. PLoS ONE 2015, 10, e0139910. [CrossRef] [PubMed]
263. Bourrie, B.C.; Willing, B.P.; Cotter, P.D. The microbiota and health promoting characteristics of the fermented beverage kefir. Front. Microbiol. 2016, 7, 647. [CrossRef] [PubMed]
264. T . J. Agric. Food Chem. 2004, 52, 5533-5538. [CrossRef] [PubMed]
265. Urdaneta, E.; Barrenetxe, J.; Aranguren, P.; Irigoyen, A.; Marzo, F.; Ibáñez, F.C. Intestinal beneficial effects of kefir-supplemented diet in rats. Nutr. Res. 2007, 27, 653-658. [CrossRef]
266. St-Onge, M.-P.; Farnworth, E.R.; Savard, T.; Chabot, D.; Mafu, A.; Jones, P.J. Kefir consumption does not alter plasma lipid levels or cholesterol fractional synthesis rates relative to milk in hyperlipidemic men: A randomized controlled trial (ISRCTN10820810). BMC Complement. Altern. Med. 2002, 2, 1. [CrossRef]
267. Ostadrahimi, A.; Taghizadeh, A.; Mobasseri, M.; Farrin, N.; Payahoo, L.; Beyramalipoor Gheshlaghi, Z.; Vahedjabbari, M. Effect of probiotic fermented milk (kefir) on glycemic control and lipid profile in type 2 diabetic patients: A randomized double-blind placebo-controlled clinical trial. Iran. J. Public Health 2015, 44, 228-237. [PubMed]
268. Givens, D.I. Dairy products: Good or bad for cardiometabolic disease? Am. J. Clin. Nutr. 2015, 101, 695-696. [CrossRef] [PubMed]
269. Astrup, A. Yogurt and dairy product consumption to prevent cardiometabolic diseases: Epidemiologic and experimental studies. Am. J. Clin. Nutr. 2014, 99, 1235S-1242S. [CrossRef] [PubMed]